Academic
Publications
Work in progress report - Congential Does contegra xenograft implantation evoke cellular immunity in children?q

Work in progress report - Congential Does contegra xenograft implantation evoke cellular immunity in children?q,Michal Wojtalik,Wojciech Mrowczynski,J

Work in progress report - Congential Does contegra xenograft implantation evoke cellular immunity in children?q  
BibTex | RIS | RefWorks Download
The aim of the study was to search for changes in subpopulations of peripheral blood lymphocytes and in their activation as the manifestation of cellular immunity against xenograft in recipients of bovine valved conduit used for right ventricle outflow tract reconstruction. Between 24-06-1999 and 19-10-2000 35 children were operated in ECC, 19 had a xenograft implanted, the rest entered the control group. Immunophenotype of lymphoid cells and T cells activation was evaluated with use of flow cytometer: preoperatively and 3, 6 and 12 months after the operation in both groups. There were no differences in numbers of CD3þ , CD4þ, CD8þ and natural killer cells between groups. A significant rise of B-cells percentages (from 15.5% to 23%) between 3rd and 6th month was noted. The T-lymphocyte activation study revealed higher numbers of CD69þ (0.17 vs. 0.09 G/l) and CD71þ (0.23 vs. 0.11 G/l) cells one year after the implantation in xenograft recipients. Difference between groups in number of CD69þ and CD71þ cells in 12th month may suggest mild activation (,10%) of these subgroups in xenograft recipients. This data may hint the presence of cellular reactivity. Changes in numbers of B-cells may evidence humoral immunity activation. Influence of these phenomena on graft survival remains to be established. q 2003 Elsevier B.V. All rights reserved.
Published in 2010.
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.